CSBR:NASDAQ
Champions Oncology Inc
US$4.70
0.00%
(0.00) 1D
ኖቬም 13, 3:57:39 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Mkt. cap
65.49 ሚ
Avg. vol.
8.15 ሺ
Volume
279.00
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
Mkt. cap
65.49 ሚ
Avg. vol.
8.15 ሺ
Volume
279.00
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
News stories
From web sources and news partners
Investor's Business Daily
·
ከ28 ደቂቃዎች በፊት
Tyson, Starbucks Lead The S&P 500, Nasdaq 100 As Investors Play Defense
The Motley Fool
·
ከ1 ሰዓት በፊት
McDonald's Is Underperforming the S&P 500 and Nasdaq-100. Could January Mark a Turning Point?
Yahoo Finance
·
ከ20 ደቂቃዎች በፊት
The S&P 500’s shot at 4 straight double-digit years is in Nvidia’s hands
The Korea Times
·
ከ1 ሰዓት በፊት
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Websitechampionsoncology.com